Estrogen receptor and its ligand, estradiol, have long been thought to be essential for survival, fertility, and female sexual differentiation and development. Consistent with this proposed crucial role, no human estrogen receptor gene mutations are known, unlike the androgen receptor, where many loss of function mutations have been found. We have generated mutant mice lacking responsiveness to estradiol by disrupting the estrogen receptor gene by gene targeting. Both male and female animals survive to adulthood with normal gross external phenotypes. Females are infertile; males have a decreased fertility. Females have hypoplastic uteri and hyperemic ovaries with no detectable corpora lutea. In adult wildtype and heterozygous females, 3-day estradiol treatment at 40 ,pg/kg stimulates a 3-to 4-fold increase in uterine wet weight and alters vaginal cornification, but the uteri and vagina do not respond in the animals with the estrogen receptor gene disruption. Prenatal male and female reproductive tract development can therefore occur in the absence ofestradiol receptormediated responsiveness.
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The estrogen receptor (ER) is a member of the steroid receptor superfamily of ligand-activated transcription factors (1) . ER and its hormone ligand, the female sex steroid 17,B-estradiol, have long been known to play critical roles in the development of feminine secondary sexual characteristics as well as in the female reproductive cycle, infertility, and maintenance of pregnancy. Estradiol is also thought to be essential for embryonic and fetal development (2) .
Supporting evidence for the crucial role of estrogen is based on pharmacological and genetic data that estrogen antagonists and inhibitors of estrogen synthesis interfere with placental function and cause abortions (2) . Overexpression mutations in the mammalian estrogen biosynthetic enzyme, aromatase, have been reported (3) to lead to gynecomastia in males because of excess conversion of androgens to estrogens. Lack of function mutations in human placental aromatase have been reported to cause maternal virilization and fetal pseudohermaphroditism in female offspring (4) . This observation suggested the need for estrogens in normal prenatal sexual development. This interpretation may be confounded, however, by the effects of secondarily increased androgen concentrations. In addition, the absence of reported human ER mutations supports the suggestion that if natural ER functional mutations do occur, they may be lethal in eutherian animals (2) .
Lack of known ER mutations is contrasted with the situation in regards to the male sex steroids, the androgens.
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Mutations in genes for the androgen receptor protein or for androgen synthetic enzymes result in abnormalities in male sexual differentiation and development (5-7) with little effect in females except for a decrease in fertility (8) .
The role of estrogen action in prenatal sexual development, however, is controversial. Endocrinological evidence for the importance of estrogens in sexual development is found in rat and rabbit embryogenesis studies (9, 10) , where estrogen synthesis is activated in male and female embryos at the time ofblastocyst implantation in the uterus. Recently, ER mRNA has been detected by the very sensitive reverse transcriptase/PCR technique in blastocysts and two-cell-stage embryos (11) . In contrast, Jost (12) , in a series of classical organ ablation experiments, demonstrated that fetal gonadectomy of mammalian males and females resulted in both sexes developing as phenotypic females, suggesting that estrogen is not needed for female sexual development. However, the presence of maternal and placental estrogens left the question of estrogen's importance in prenatal sexual development unresolved.
Nevertheless, there is no doubt that estrogen plays a central role in normal postnatal female physiology and in female pathology, where its importance in breast and uterine cancer, osteoporosis, and cardiovascular disease is well known although poorly understood. Besides the normal physiology and endocrinology of estrogen action, the mechanisms for hormonal stimulation have also been postulated to involve other cellular signaling mechanisms (13) (14) (15) pared from these plates was pooled into groups of four and was screened by PCR amplification to detect targeting (22) . PCR Primers. Oligo PCR Amplification. The 3' end ofthe PGK gene, containing the poly(A) addition signal, was sequenced. From this sequence, oligo 5 was designed for use in conjunction with oligo 6 to amplify a 649-bp fragment diagnostic of a successfully targeted ER gene (see Fig. 1 ). For PCR screening the DNA was from pools of four colonies of ES cells. PCR was also used to distinguish normal, heterozygous, and homozygous mutant animals (see Fig. 2 ).
Mouse Breeding. Electroporation was used to introduce the targeting construct into ES cells, which were then exposed to ganciclovir and G418. About 1800 surviving colonies were screened with primers 5 and 6 to find two in which homologous recombination had occurred as judged by the amplification of the 649-bp fragment diagnostic of targeting (Fig. 1C) . Southern blot analysis with a Neo probe confirmed that the targeted construct was integrated at a single site (data not shown).
Generating Animals. Cells from one of these targeted ES clones were injected into blastocysts, and four male chimeras and four female chimeras were obtained. After several matings with different males the chimeric females showed no germ-line transmission. Two chimeric males transmitted the targeted gene through their germ line to produce heterozygous male and female animals. Heterozygous animals were then mated to produce homozygous animals. Fig. 2 However, statistical analysis using a x2 goodness-of-fit test indicated that the deviation from expectation was not significant (P = 0.07).
Phenotype of the Animals. The external phenotypes of animals of both sexes that are homozygous for the disrupted gene were normal. Internally only the females showed noticeable gross differences from normal, with hypoplastic uteri as well as ovaries that lacked corpora lutea (see Fig. 4) .
Histologically, the uteri and hyperemic cystic ovaries were abnormal. Fig. 3A shows a histological section of an ovary from a wild-type animal. Primary follicles can be seen, with examples of preantral tertiary follicles and corpora lutea present in the section. In contrast, ovaries from the homozygous mutant animals show classic cystic and hemorrhagic follicles containing few if any granulosa cells (Fig. 3B) . A few primary follicles can be seen, but no corpora lutea were observed in these ovaries. The histology of the uterus showed the presence of all major uterine cell types, but the stromal, epithelial, and myometrial tissue compartments were present in diminished size. Uterine glands were present as well as ciliated epithelial cells in the oviduct (data not presented).
Males appear overtly normal, but testis weight was low compared with wild-type or heterozygote animals. On the other hand, seminal vesicle and coagulating gland weights were not significantly different. Sperm were present in the testis and epididymus, but the sperm count was low, only 10% of the control level. Functionality and motility of the sperm from the recessive males are not yet known.
Responses to Estrogen. To test for estrogen responsiveness, adult females were treated for 3 days with estradiol at levels known to increase uterine wet weight, induce hyperemia, and alter vaginal epithelial cytology in normal animals (24) . The wild-type and heterozygous animals responded normally compared with untreated controls (Fig. 4A) by an increase in uterine wet weight of 3-to 4-fold (Fig. 4B) . The uteri from wild type (Fig. 4B ) and heterozygotes (data not presented) became hyperemic after a 3-day bioassay. The uteri of the homozygous ER-disrupted animals did not respond with either an increase in uterine weight wet or hyperemia (Fig. 4 C and D). Unlike wild-type and heterozygous animals, ERdisrupted animals treated with estradiol for 4-6 hr showed no uterine water imbibition or uterine hyperemia (data not presented). Vaginal cytology after estradiol treatment showed an increased number of cornified epithelial cells in the wild-type and heterozygous animals but was unaltered in ER-disrupted animals (data not shown).
Estrogen Binding. Ligand-binding analyses of uterine tissue from the ER-disrupted animals showed detectable estradiol binding (25) at about 5% of the wild-type level (60-70 fmol/100 ,ug of DNA), with a dissociation constant similar to that of the wild type (0.7 nM). Low concentrations of ER protein were confirmed by an ELISA (Abbott) using two antibodies to the C terminus of the ER protein. "Splicing over" of insertional mutations (26) or nonsense codons (27) has been observed previously. In vivo reinitiation of translation after a nonsense mutation, resulting in a ligandnonresponsive receptor protein, has also been seen previously in the steroid receptor superfamily (28).
Fertility. All homozygous mutant females are infertile.
None showed any lordosis posture or receptiveness to wildtype males even when treated with estrogen. This behavior suggests absence of estrogen responsiveness in the central nervous system. Male fertility was tested with harem pairings to known fertile wild-type females. Fertility was reduced, but not abolished, since only 3 of 15 paired males produced any offspring. However, the males that initially demonstrated fertility have not to date sired any more litters after several pairings. No vaginal plugs were found in any of the matings of both sexes of homozygous mutant animals, with the exception of the 3 fertile males.
DISCUSSION
The homozygous mutant mice with ER-disrupted genes appear healthy, and with the exception of fertility problems in both male and female animals, there are no obvious problems in prenatal sexual development. This is surprising because of the known importance of estrogens in breast and uterine growth and because of their effects on cardiovascular disease and in preventing bone loss after menopause and after ovariectomy in mice. Possibly there is a parallel regulatory pathway that can make up for the lack of estrogen responsiveness during prenatal sexual differentiation and development. It is also possible (see below) that some residual functions are retained by the disrupted gene, but in either case, these alternate pathways do not enable the uterus or vagina to respond to estradiol. Growth factors, such as insulin-like growth factor 1, epidermal growth factor, and transforming growth factor a, may be involved in possible alternative regulatory pathways, since they have been linked to estrogen action in uterine tissue (14, 15, 29) .
Other members of the steroid receptor superfamily have been targeted by homologous recombination. In some isoforms of the retinoic acid receptor (RAR) family the gene disruptions have resulted in alterations in phenotype while in others they have not (30) (31) (32) . Disruption of one N-terminal exon of the RARa-1 and RARy-2 isoforms resulted in a normal phenotype, while disruption of a different N-terminal exon of the RARa and RARy genes produced early postnatal lethality.
Traditional pronuclear injection transgenic techniques which produce overexpression of the ER result in aberrant reproductive phenotypes with alterations in the length of parturition.tt However, as in our ER-disrupted animals, no abnormalities in prenatal sexual development are seen, although at the neuroendocrine, end organ, and gonadal level, reproductive function appears to be severely compromised. The observation of apparently normal development of prenatal sexual phenotypes, associated with fertility problems, suggests that ER defects may be responsible for some human infertility problems. It will now be interesting to see if any human male or female infertilities might be caused by ER mutations or in genes regulated by ER. Proc. Natl. Acad. Sci. USA 90 (1993) with hypertension (34) and spontaneous abortions as well as increased susceptibility to breast cancer (35) , but to date there have been no reports of ER changes in relation to fertility. Further studies into the susceptibility of the ERdisrupted mice to hypertension and mammary gland cancer will be valuable in assessing nonestrogenic risk factors. Assessment of bone strength, cardiovascular disease susceptibility, and atherosclerosis during aging will also help us learn more about the roles played by the ER in these pathophysiologies.
Our observation that we can still detect about 5% of normal estradiol binding in uterine preparations from animals homozygous for the gene disruption and demonstrably unresponsive to estradiol is especially interesting. The binding has the same affinity as determined for normal estrogen receptor. While the gene disruption that we have constructed abolished estrogen responsiveness, it is possible that a protein product able to bind estrogen may still be generated; for example a "splicing over" event may have occurred that eliminated exon 2. Examples are known of exons being "spliced over" when a nonsense codon is found in an exon (27) or when Neo has been inserted into the exon by targeting (26) . Examples of mutant ER isoforms lacking different exons have been identified by mRNA analysis from primary tumors or cancer cell lines (36) . A recent report has shown in normal rat brain tissue an ER isoform lacking exon 4 (37); however this protein would not be capable of binding ligand. An altered form of the normal receptor may be synthesized after the ER gene disruption. If so, it is incapable of mediating estrogen responsiveness, either because of its structure or because it is synthesized at too low a level. We have shown earlier that uterine responsiveness to estrogen does not occur in mice if receptor levels are decreased to below 20% of control (38) .
Interestingly, the testicular feminization mouse (39) does not respond to androgen because of a frameshift mutation in the androgen receptor N-terminal domain. Low levels of androgen receptor binding are detectable. Reinitiation of translation downstream of the nonsense codon is believed to occur, such that the C-terminal ligand-binding domain is present in very low amounts without the N-terminal domain (28) . It is tempting to speculate that something similar may be happening with our ER-disrupted mice.
Alternatively, the ER form detected by binding in the homozygous mutant animals may represent another, previously undetected, estrogen-binding protein. Further studies will be needed to characterize the molecular nature and possible function of the residual estrogen binding activity in our homozygous mutant mice.
In any case, the homozygous mutants with the ERdisrupted genes are not physiologically responsive to estrogens by several classical bioassays of estrogenic activityincrease in uterine water imbibition, stimulation of uterine hyperemia, and change in vaginal cornification. Detection of ER early in development (11) and the apparent role of estrogen in blastocyst activation (9, 10, 33) make it remarkable that prenatal sexual development is not altered and that lethality did not occur in the animals with their ER genes disrupted.
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